BRPI0407213A - Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionados - Google Patents
Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionadosInfo
- Publication number
- BRPI0407213A BRPI0407213A BR0407213-8A BRPI0407213A BRPI0407213A BR PI0407213 A BRPI0407213 A BR PI0407213A BR PI0407213 A BRPI0407213 A BR PI0407213A BR PI0407213 A BRPI0407213 A BR PI0407213A
- Authority
- BR
- Brazil
- Prior art keywords
- preeclampsia
- elevation
- determining
- marinobufagenin
- employing
- Prior art date
Links
- 201000011461 pre-eclampsia Diseases 0.000 title abstract 4
- FRYICJTUIXEEGK-UHFFFAOYSA-N 5beta-hydroxyldesacetylcinobufagin Natural products CC12CCC(C3(CCC(O)CC3(O)CC3)C)C3C11OC1C(O)C2C=1C=CC(=O)OC=1 FRYICJTUIXEEGK-UHFFFAOYSA-N 0.000 title abstract 2
- JMNQTHQLNRILMH-OBBGIPBRSA-N marinobufagenin Chemical compound C=1([C@H]2C[C@H]3O[C@@]43[C@H]3[C@@H]([C@]5(CC[C@H](O)C[C@@]5(O)CC3)C)CC[C@@]42C)C=CC(=O)OC=1 JMNQTHQLNRILMH-OBBGIPBRSA-N 0.000 title abstract 2
- 210000002700 urine Anatomy 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9453—Cardioregulators, e.g. antihypotensives, antiarrhythmics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44473003P | 2003-02-04 | 2003-02-04 | |
| PCT/US2004/002802 WO2004071273A2 (en) | 2003-02-04 | 2004-02-02 | Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0407213A true BRPI0407213A (pt) | 2006-02-07 |
Family
ID=32869296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0407213-8A BRPI0407213A (pt) | 2003-02-04 | 2004-02-02 | Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionados |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7439071B2 (enExample) |
| EP (1) | EP1592967A4 (enExample) |
| JP (1) | JP4625800B2 (enExample) |
| AU (1) | AU2004210650C1 (enExample) |
| BR (1) | BRPI0407213A (enExample) |
| CA (1) | CA2515012A1 (enExample) |
| WO (1) | WO2004071273A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7402313B2 (en) | 2002-07-25 | 2008-07-22 | Charles David Adair | Method for controlling preeclampsia and eclampsia |
| US7794716B2 (en) | 2002-07-25 | 2010-09-14 | Glenveigh Pharmaceuticals, Llc | Antibody composition and passive immunization against pregnancy-induced hypertension |
| ATE537823T1 (de) * | 2004-10-19 | 2012-01-15 | Univ Tulane | Verfahren zur behandlung von präeklampsie beim menschen mit resibufagenin |
| US8038997B2 (en) | 2005-06-27 | 2011-10-18 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Anti-marinobufagenin antibodies and methods for their use |
| US20070257366A1 (en) * | 2006-05-03 | 2007-11-08 | Taiwan Semiconductor Manufacturing Company, Ltd. | Barrier layer for semiconductor interconnect structure |
| US20080299602A1 (en) * | 2007-05-31 | 2008-12-04 | Puschett Jules B | Methods of Employing Vascular Leakage to Diagnose a Capillary Leak Disorder |
| WO2010104646A1 (en) * | 2009-03-09 | 2010-09-16 | Scott and White Memorial Hospital | Method of testing a patient for hypertension and related method of treatment and test kit |
| US20110008904A1 (en) * | 2009-07-10 | 2011-01-13 | Scott And White Memorial Hospital And Scott, Sherwood, And Brindley Foundation | Method for determining if a patient has a traumatic brain injury and related apparatus |
| US20110207154A1 (en) * | 2010-01-12 | 2011-08-25 | Scott & White Healthcare | Method for determination of marinobufagenin levels and compounds employable in such method |
| US20160299130A1 (en) * | 2015-04-09 | 2016-10-13 | Jules B. Puschett | Telocinobufagin (TCINO) in the Diagnosis and Pathogenesis of Preeclampsia, Traumatic Brain Injury and Acute Respiratory Distress Syndrome |
| EP3813879A1 (en) * | 2018-06-21 | 2021-05-05 | CTS Biopharma LLC | Anti-marinobufagenin antibodies and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5079171A (en) * | 1988-09-15 | 1992-01-07 | Adeza Biomedical Corporation | Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin |
| EP0440750A4 (en) * | 1988-12-14 | 1991-10-09 | The Regents Of The University Of California | Diagnostic assay for the detection of preeclampsia |
| GB9213934D0 (en) * | 1992-06-30 | 1992-08-12 | Smithkline Beecham Corp | Chemical compounds |
| US5770376A (en) | 1992-12-02 | 1998-06-23 | Biomedical Sciences Research Laboratories, Inc. | Method of diagnosing and treating myocardial infarction and hypertension |
| WO1994012210A1 (en) | 1992-12-02 | 1994-06-09 | Bagrov Alexei Y | Anti-edlf antibody, composition thereof and method of diagnosing and treating cardiac arrhythmias, hypertension |
| US5543138A (en) * | 1994-03-10 | 1996-08-06 | Genetics Institute, Inc. | Methods of diagnosing and treating preeclampsia |
| GB9618931D0 (en) * | 1996-09-11 | 1996-10-23 | Univ London | Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes |
| US20030044856A1 (en) | 1997-09-26 | 2003-03-06 | Puschett Jules B. | Method of determining volume dependent hypertension through protein reduction in phosphorylation or concentration and related apparatus |
| JPH11271222A (ja) * | 1998-03-24 | 1999-10-05 | Sekisui Chem Co Ltd | 尿検査方法 |
| US7794716B2 (en) * | 2002-07-25 | 2010-09-14 | Glenveigh Pharmaceuticals, Llc | Antibody composition and passive immunization against pregnancy-induced hypertension |
| US10167609B1 (en) | 2018-01-12 | 2019-01-01 | Cashman Dredging & Marine Contracting Co., LLC | Carouseling articulated dredge and barge |
-
2004
- 2004-02-02 JP JP2006503224A patent/JP4625800B2/ja not_active Expired - Fee Related
- 2004-02-02 US US10/544,468 patent/US7439071B2/en not_active Expired - Fee Related
- 2004-02-02 CA CA002515012A patent/CA2515012A1/en not_active Abandoned
- 2004-02-02 AU AU2004210650A patent/AU2004210650C1/en not_active Ceased
- 2004-02-02 EP EP04707392A patent/EP1592967A4/en not_active Withdrawn
- 2004-02-02 WO PCT/US2004/002802 patent/WO2004071273A2/en not_active Ceased
- 2004-02-02 BR BR0407213-8A patent/BRPI0407213A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004210650A1 (en) | 2004-08-26 |
| EP1592967A4 (en) | 2007-06-20 |
| US20060263891A1 (en) | 2006-11-23 |
| JP2006517670A (ja) | 2006-07-27 |
| WO2004071273A2 (en) | 2004-08-26 |
| JP4625800B2 (ja) | 2011-02-02 |
| AU2004210650B2 (en) | 2009-07-30 |
| AU2004210650C1 (en) | 2010-01-14 |
| EP1592967A2 (en) | 2005-11-09 |
| WO2004071273A3 (en) | 2005-02-03 |
| CA2515012A1 (en) | 2004-08-26 |
| US7439071B2 (en) | 2008-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nekoofar et al. | pH of pus collected from periapical abscesses | |
| Kiss et al. | Age-related decline in perception of prosodic affect | |
| EA200801071A1 (ru) | Способы и композиции для применения в целях лечения пациентов с положительным по аутоантителам заболеванием | |
| CY1116107T1 (el) | Ενωσεις για χρηση στην αγωγη αυτοανοσων παθησεων, ανοσο-αλλεργικων παθησεων και απορριψης μεταμοσχευσης οργανων ή ιστων | |
| DE60326214D1 (de) | Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten | |
| BRPI0407213A (pt) | Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionados | |
| MX2009003562A (es) | Ensayo elisa para la deteccion de vegf. | |
| BR112012008161B8 (pt) | dispositivo que pode ser usado no corpo do usuário para prover vácuo para usos clínicos | |
| BRPI0515758A (pt) | dispositivo de ensaio de diagnóstico | |
| ATE481032T1 (de) | Vorrichtung, system und verfahren zur in-vivo- probenentnahme | |
| CY1107901T1 (el) | Μεθοδος προσδιορισμου για ασθενεια alzheimer | |
| WO2004071427A3 (en) | Screening and treatment methods for prevention of preterm delivery | |
| CY1107715T1 (el) | Διαγνωση και αγωγη του καρκινου του προστατη | |
| WO2007092427A3 (en) | Treatment of endotoxemia using endotoxin neutralizing agents | |
| AR048031A1 (es) | Metodos para estimar la necesidad y efectividad de la terapia con antioxidantes | |
| FR2885536B1 (fr) | Composition a base d'ethers de dianhydrohexitol pour le traitement d'une matiere autre que le corps humain | |
| JP2006517670A5 (enExample) | ||
| CY1107921T1 (el) | Μεθοδος για την προγνωση της αθροιστικης επιβιωσης ασθενων | |
| BRPI0518795A2 (pt) | mÉtodos para determinar a eficÁcia de um tratamento terapÊutico anti-inflamatàrio de um indivÍduo e para selecionar um indivÍduo que sofre de uma certa doenÇa inflamatària para receber tratamento terapÊutico anti-inflamatàrio | |
| WO2005030265A3 (en) | Optical imaging of endometriosis | |
| BR0113646A (pt) | Tratamento de distúrbios inflamatórios | |
| ATE537823T1 (de) | Verfahren zur behandlung von präeklampsie beim menschen mit resibufagenin | |
| BRPI0508053A (pt) | método de combater toxicidade causada por um composto antifolato, e de tratar uma doença, usos de enzima que possui atividade de carbóxi-peptidase g, de composto antifolato, de agente de resgate de rota de folato, e de enzima que possui atividade de carbóxi-peptidase g e de um agente de resgate de rota de folato, sistema terapêutico, e, método ex vivo de clivar um grupo l-glutamato terminal de um composto, de determinar a taxa e/ou extenção de clivagem de um composto, e de clivagem de um composto | |
| Fernandez-Bello | Monitoring of new therapies for hemophilia | |
| Wu | Estrogen Loss Activates Memory T-Cells That Is Physiological Postpartum but Pathological Postmenopause Increasing Bone Fragility |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A, 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |